Eyal C. Attar - SVP, Chief Medical Officer, Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Medical Officer, Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eyal C. Attar since 10/5/2023

Holdings reported by Eyal C. Attar for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 57.2K $211K $3.68 Jun 3, 2022 Direct
Common Stock 159 $585 $3.68 Jun 3, 2022 By adult child

Transactions reported by Eyal C. Attar for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.